SyntheticMR AB (publ)
Research SyntheticMR AB (publ) (SYNT.ST) on Bullrun: market cap SEK 55.56M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSYNT.ST
- ExchangeXSAT
- CountrySweden
- SectorHealthcare
- IndustryHealth Information Services
- CurrencySEK
- Market capSEK 55.56M
- Financial periodQ2 2026
- RevenueSEK 13.99M
- Net income-SEK 6.09M
- Free cash flow-SEK 4.55M
- Gross margin113.3%
Valuation Snapshot
latest market cap is SEK 55.56M.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | SEK 55.56M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About SyntheticMR AB (publ)
SyntheticMR AB (publ) engages in the development and marketing of imaging and software solutions for magnetic resonance imaging (MRI) in Sweden and internationally. The company also offers SyMRI NEURO, which includes multiple contrast images, automatic segmentation, volumetric measurements and quantitative maps of the patients; SyMRI Spine & Knee; SyMRI MSK Spine and SyMRI Knee that offers a solution in obtaining anatomical information from a single MRI sequence;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is SyntheticMR AB (publ)'s market cap?
SyntheticMR AB (publ)'s market capitalization is SEK 55.56M.
What does SyntheticMR AB (publ) do?
SyntheticMR AB (publ) engages in the development and marketing of imaging and software solutions for magnetic resonance imaging (MRI) in Sweden and internationally. The company also offers SyMRI NEURO, which includes multiple contrast images, automatic segmentation, volumetric measurements and quantitative maps of the patients; SyMRI Spine & Knee; SyMRI MSK Spine and SyMRI Knee that offers a solution in obtaining anatomical information from a single MRI sequence; and cNeuro, a platform for interdisciplinary clinical work in radiology, neurology, and nuclear medicine.